Viewing Study NCT05411718


Ignite Creation Date: 2025-12-25 @ 4:54 AM
Ignite Modification Date: 2026-03-13 @ 3:07 AM
Study NCT ID: NCT05411718
Status: RECRUITING
Last Update Posted: 2025-11-13
First Post: 2022-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None T Cells View
None Colorectal Cancer View
None Lynch Syndrome View
Keywords: